Research location

Flensburg

Germany

Published trials35

Site observations35

Linked trials published35

Page1 / 1

Research activity in Flensburg

Germany

CureCurrent currently publishes aggregate city-level research activity for this location: 35 trials and 35 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Flensburg

35 linked trials · page 1 of 1

Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Under Real-world ConditionsNCT07052396 · 2025-07-01 · 1 site observation

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung CancerNCT06868277 · 2025-04-10 · 1 site observation

Study to Confirm Efficacy and Feasibility of Tarlatamab Treatment in Patients With Extensive Stage Small-cell Lung Cancer With Poor Performance StatusNCT07803848 · 2025-01-01 · 1 site observation

A Non-interventional, Prospective Study With BenralizumabNCT06422078 · 2024-07-25 · 1 site observation

A Study for Observing Severe Asthma in Patients Treated With TezepelumabNCT05677139 · 2022-12-13 · 1 site observation

REported Outcomes in COPD With Trixeo in Real worlD in GermanyNCT05311306 · 2022-03-15 · 1 site observation

Change in Patient-Reported Outcomes in Severe Eosinophilic Asthma Patients Treated With Benralizumab Under Real-life ConditionsNCT04184284 · 2019-11-15 · 1 site observation

Re-evaluation of Optimal Re-synchronisation Therapy in Patients With Chronic Heart FailureNCT03494933 · 2018-09-01 · 1 site observation

Patient Preference for Pegfilgrastim (Neulasta®) Application FormsNCT03619993 · 2018-06-25 · 1 site observation

A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)NCT02367781 · 2015-04-16 · 1 site observation

Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation TherapyNCT02173769 · 2014-06-01 · 1 site observation

Azilect® In Wearing-Off (AIWO)NCT02384512 · 2014-01-01 · 1 site observation

Hypofractionation With Simultaneous Integrated Boost for Early Breast CancerNCT01948726 · 2013-12-01 · 1 site observation

Efficacy Study of Herceptin to Treat HER2-negative CTC Breast CancerNCT01548677 · 2013-04-01 · 1 site observation

Treatment Study of Negative Pressure Wound Therapy for Diabetic Foot WoundsNCT01480362 · 2011-11-01 · 1 site observation

Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe Chronic Obstructive Pulmonary Disease (COPD) (DACOTA)NCT01285167 · 2010-08-01 · 1 site observation

Assessment of Chronic Obstructive Pulmonary Disease (COPD) Therapy From the Physicians Perspective Using Tiotropium as an ExampleNCT01036763 · 2010-01-01 · 1 site observation

A Study on the Effect of 2 Pen Devices on HbA1cNCT00985712 · 2009-10-01 · 1 site observation

Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or mNCT00997230 · 2009-09-01 · 1 site observation

Observational Non-Interventional Study With Spiriva Respimat in COPD PatientsNCT00699699 · 2008-06-01 · 1 site observation

Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent AsthmaNCT00608218 · 2008-01-01 · 1 site observation

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DNCT00490139 · 2007-05-16 · 1 site observation

Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced DyspnoeaNCT00540163 · 2007-04-01 · 1 site observation

Local Phase 4 Pan-European SMART StudyNCT00463866 · 2007-03-01 · 1 site observation

Transdermal Rotigotine User Surveillance StudyNCT00599339 · 2006-06-01 · 1 site observation

To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given TogetherNCT00318461 · 2006-05-01 · 1 site observation

DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in AdultsNCT00252863 · 2004-12-01 · 1 site observation

An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT00949910 · 2004-11-01 · 1 site observation

Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 DiabetesNCT00095082 · 2004-09-01 · 1 site observation

Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical PracticeNCT01077258 · 2004-04-01 · 1 site observation

Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 DiabetesNCT00605020 · 2003-12-02 · 1 site observation

Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical PracticeNCT01078090 · 2003-04-01 · 1 site observation

Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 DiabetesNCT00283751 · 2003-03-01 · 1 site observation

Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 DiabetesNCT00312104 · 2002-04-01 · 1 site observation

Safety and Efficacy of Insulin Aspart in Subjects With Type 1 DiabetesNCT01707134 · 1997-09-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.